Evidence map›Paper›PMID 32043020›Full record

ArticleJACC. Basic to translational science2020

Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis.

Jianting Yao, Weiwei Gao, Yu Wang, Lu Wang, Kamal Diabakte, Jinyang Li, Jiemei Yang, Yongxing Jiang, Yuerong Liu, Shuyuan Guo and 21 more

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Sonodynamic therapy for the treatment of atherosclerosis.Journal of pharmaceutical analysis · 2024
    Review
  8. Review
  9. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  10. Review
  11. Recent Advances for Dynamic-Based Therapy of Atherosclerosis.International journal of nanomedicine · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Sonodynamic therapy reduces iron retention of hemorrhagic plaque.Bioengineering & translational medicine · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 4 institutions in 2 countries.

Jianting YaoDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Weiwei GaoDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Yu WangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Lu WangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Kamal DiabakteDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Jinyang LiDepartment of Pathophysiology and Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University, Harbin, People's Republic of China.
Jiemei YangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Yongxing JiangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Yuerong LiuDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Shuyuan GuoDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Xuezhu ZhaoDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Zhengyu CaoDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Xi ChenDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Qiannan LiDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Haiyu ZhangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Wei WangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Zhen TianDepartment of Pathophysiology and Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University, Harbin, People's Republic of China.
Bicheng LiDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Fang TianDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Guodong WuDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Shirin PourteymourDepartment of Medicine, Karolinska Institute, Stockholm, Sweden.
Xi HuangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Fancheng TanDepartment of Pathophysiology and Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University, Harbin, People's Republic of China.
Xiaoru CaoDepartment of Pathophysiology and Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University, Harbin, People's Republic of China.
Zhuowen YangDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Kang LiDepartment of Epidemiology and Biostatistics, Harbin Medical University, Harbin, People's Republic of China.
Yan ZhangSchool of Life Science and Technology, Research Center for Computational Biology, Harbin Institute of Technology, Harbin, People's Republic of China.
Yong LiDepartment of Positron Emission Tomography-Computed Tomography, the First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Zhiguo ZhangLaboratory of Photo- and Sono-theranostic Technologies and Condensed Matter Science and Technology Institute, Harbin Institute of Technology, Harbin, People's Republic of China.
Hong JinDepartment of Medicine, Karolinska Institute, Stockholm, Sweden.
Ye TianDepartment of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CNKarolinska Institutet · SEHarbin Institute of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During atherosclerosis plaque progression, pathological intraplaque angiogenesis leads to plaque rupture accompanied by thrombosis, which is probably the most important cause of arteries complications such as cerebral and myocardial infarction. Even though few treatments are available to mitigate plaque rupture, further investigation is required to develop a robust optimized therapeutic method. In this study using rabbit and mouse atherosclerotic models, sinoporphyrin sodium (DVDMS)-mediated sonodynamic therapy reduced abnormal angiogenesis and plaque rupture. Briefly, DVDMS is injected to animals, and then the plaque was locally exposed to pulse ultrasound for a few minutes. Furthermore, a small size clinical trial was conducted on patients with atherosclerosis. Notably, a significant reduction of arterial inflammation and angiogenesis was recorded following a short period of DVDMS-mediated sonodynamic therapy treatment. This beneficial outcome was almost equivalent to the therapeutic outcome after 3-month intensive statin treatment.

Indexed as

ALA, 5-aminolevulinic acidApoE, apolipoprotein Eapoptosis-induced apoptosisatherosclerotic plaqueChIP, chromatin immunoprecipitationDVDMS-SDT, sinoporphyrin sodium-mediated sonodynamic therapyDVDMS, sinoporphyrin sodiumendothelial cellHIF, hypoxia inducible factorHUVEC, human umbilical vein endothelial cellsmacrophageMVE, normalized maximal video-intensity enhancementneovascularizationSDT, sonodynamic therapysonodynamic therapySP, specificity proteinTBR, target-to-background ratioVEGF-A, vascular endothelial growth factor A

Identifiers

PMID32043020
PMCPMC7000870
OpenAlexW2997833012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.